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Abstract
West Nile virus (WNV) infection can result in severe neuroinvasive disease, particularly in persons with advanced age. As
rodent models demonstrate that T cells play an important role in limiting WNV infection, and strong T cell responses to WNV
have been observed in humans, we postulated that inadequate antiviral T cell immunity was involved in neurologic
sequelae and the more severe outcomes associated with age. We previously reported the discovery of six HLA-A*0201
restricted WNV peptide epitopes, with the dominant T cell targets in naturally infected individuals being SVG9 (Env) and
SLF9 (NS4b). Here, memory phenotype and polyfunctional CD8+ T cell responses to these dominant epitopes were assessed
in 40 WNV seropositive patients displaying diverse clinical symptoms. The patients’ PBMC were stained with HLA-I
multimers loaded with the SVG9 and SLF9 epitopes and analyzed by multicolor flow cytometry. WNV-specific CD8+ T cells
were found in peripheral blood several months post infection. The number of WNV-specific T cells in older individuals was
the same, if not greater, than in younger members of the cohort. WNV-specific T cells were predominantly monofunctional
for CD107a, MIP-1b, TNFa, IL-2, or IFNc. When CD8+ T cell responses were stratified by disease severity, an increased number
of terminally differentiated, memory phenotype (CD45RA+ CD272 CCR72 CD57+) T cells were detected in patients suffering
from viral neuroinvasion. In conclusion, T cells of a terminally differentiated/cytolytic profile are associated with
neuroinvasion and, regardless of age, monofunctional T cells persist following infection. These data provide the first
indication that particular CD8+ T cell phenotypes are associated with disease outcome following WNV infection.
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Introduction
West Nile virus (WNV) was first reported in the eastern United
States in 1999 and has since spread westward through the entire
North American continent. Reported WNV cases peaked at about
10,000 in 2003 and WNV continues to represent a considerable
public health threat. Among infected individuals, almost 50% report
neurologic symptoms due to encephalitis or meningitis (http://
www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount09_
detailed.htm). Furthermore, rates of WNV infection are expected
to increase if global temperatures rise [1]. At this time there is no
specific treatment for West Nile virus infection; intensive supportive
therapy is directed toward the complications of brain infections,
with anti-inflammatory medications, intravenous fluids, and
intensive medical monitoring applied to severe cases. There is no
prophylactic vaccine.
Most primary WNV infections are asymptomatic or exhibit a
mild, flu-like illness that lasts no more than a few days. Successful
resolution of primary WNV infection is associated with develop-
ment of adaptive immunity to the virus. Some individuals undergo
neurologic complications that can arise long after the acute phase
of the infection has been resolved [2]. In addition, recent evidence
suggests long term persistence of WNV, in a small but significant
number of infected humans [3]. Given that MHC class I restricted
CD8+ cytotoxic T lymphocytes (CTL) play an important role in
controlling WNV infection in animal models [4,5,6], we reasoned
that the severe CNS sequelae of WNV infection could be related
to a lack of T cell immune control of the virus infection.
The objective of this study was to delineate whether CD8+ T
cell immunity to WNV was related to neuroinvasive disease. This
included assessment of memory T cell phenotypes, i.e., CD45RA
(a spliced isoform of the leukocyte common antigen), CD27 (a
member of the TNF receptor superfamily), CD57 (an indicator of
T cells with limited proliferation potential) and CCR7 (lymph
node homing receptor), and polyfunctional T cell activity, i.e.,
production of more than one immune mediator that are known to
be involved in control of other viral infections [7,8]. While no
consensus has been reached as to what a ‘‘protective’’ T cell
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phenotype might be, a polyfunctional population of CD8+ T
memory cells with a naı¨ve-like phenotype (CD45RA+, CD27+,
CCR72) has been reported following vaccination with another
flavivirus, yellow fever virus, in addition to Vaccinia and HIV
infections [7,8,9]. Thus, we hypothesized that a lack of polyfunc-
tional T cells with an effector memory phenotype would be related
to neuroinvasive WNV infection. Our findings indicate that
memory CD8+ T cells in persons with neuroinvasive disease were
memory T cells are skewed towards a terminally differentiated,
memory phenotype that was predominately monofunctional.
Results
Long term memory T cells specific for SVG9 and SLF9 are
found at a relatively high frequency
Previously, we comparatively analyzed thousands of peptide
ligands eluted from the HLA class I of infected cells, discovering
six WNV-encoded, HLA-A*0201 restricted, peptide epitopes
[10,11]. Two of the six epitopes identified in these studies,
SVG9 and SLF9, generated the most IFN-c producing T cells in
WNV seropositive donors. The other four epitopes generated
comparatively little IFN-c, possibly because these ligands were
recognized by low frequency T cells or because these T cells do not
make IFN-c upon stimulation. To have a better understanding of
the frequency of CD8+ T cells specific for the six HLA-A*0201
WNV peptides, we generated peptide-MHC multimers loaded
with each of the peptides described (Table 1).
Our results demonstrated that the immunodominance of SVG9
and SLF9 that we previously showed by production of IFN-c in
vitro was also evidenced by direct staining of uncultured CD8+ T
cells with multimers specific for SVG9 and SLF9. T cells specific
for these two WNV epitopes and the control, EBV epitope GLC9
were detected in the PBMC of the WNV-infected but not
uninfected participants (Figure 1A). Memory T cells specific for
immunodominant epitope SVG9 were recognized with a median
frequency of 347/106 CD3+ CD8+ cells (range, 15 - 8,529). Cells
that were specific for nonstructural protein NS4b epitope SLF9
were recognized with a median frequency of 370/106 CD3+ CD8+
cells (range 76 - 4,144), similar to SVG9. By comparison, the well
characterized HLA-A*0201 restricted immunodominant EBV
BMLF-1 (GLC9) epitope was recognized with a frequency of
467/106 CD3+ CD8+ T cells (range 19 - 53,129) in the WNV
positive group. Thus, after acute WNV infection, populations of
peripheral memory CD8+ T cells specific for SVG9 and SLF9
were maintained at frequencies similar to T cells specific for an
immunodominant lytic epitope of the persistent herpesvirus EBV.
In contrast to SVG9 and SLF9, the frequency of T cells specific
for the four subdominant WNV epitopes (RLD10, SLT9, YTM9
and ATW9) did not differ between WNV seropositive and
seronegative persons (p.0.05) (Figure 1B). These data indicate
that the lack of a T cell response in the IFN-c ELISPOT assay
corresponds to a dearth of circulating T cells with T cell receptors
specific for these subdominant WNV/A*0201 peptides. To
confirm that T cells do recognize these four viral peptides, albeit
at a frequency below the multimer staining-assay detection limit in
unstimulated PBMC, T cell lines were successfully generated to all
of these epitopes. Thus, memory T cells specific for subdominant
WNV epitopes exist at a frequency below the detection limit of
both IFN-c ELISPOT and p-MHC staining.
Relationship between age and WNV memory T cell
frequency
Advanced age is a risk factor for WNV disease severity [12]. We
therefore examined correlations between age and SVG9/SLF9-
specific T cell frequencies and found a significant positive
correlation (p,0.01) of age and SVG9 p-MHC multimer-positive
cell frequency (Figure 2A). When the cohort was stratified by age,
there was a significant increase (p,0.05) in SVG9-specific T cells
in the 41–59 and $60 age groups compared to subjects who were
,40 years of age at the time of infection (Figure 2C). Conversely,
there was no significant correlation between SLF9 p-MHC
multimer positive cell frequency and age (Figure 2B) and no
differences in SLF9 frequency among age groups (Figure 2D). In
addition, there was no significant linear correlation with age and
EBV frequency, suggesting this is WNV SVG9 specific. These
data demonstrate age-related changes in WNV-specific, memory
CD8+ T cell frequencies, and that these changes are epitope
specific. Moreover, the frequency of T cells specific for the most
dominant WNV/A*0201 epitope increased with age.
In contrast to the association of age with increases in T cells
specific for SVG9, subjects with neuroinvasive disease did not
exhibit an elevated frequency of SVG9 or SLF9 specific memory
T cells (data not shown). However it should be noted that in our
cohort there was not a significant age-related association with
neuroinvasive disease; 14% for subjects ,40 years of age and 36%
for those aged 60 and over (p = 0.61). Thus, the increase in SVG9
specific T cells with age observed in our cohort was independent of
disease severity.
Long term memory surface phenotypes of p-MHC
reactive cells in WNV seropositive subjects
Little information is available pertaining to the surface
phenotype of long-term memory, CD8+ T cells to WNV. A
recent study showed that equal numbers of CD45RA+/2 CD272
(effector phenotype) and CD45RA2 CD27+ (memory phenotype)
WNV-specific CD8+ T cells are found one month after infection
[13]. This study utilized antigenic stimulation, a method that
changes surface phenotype. Here, we investigated pre-antigenic
stimulation ex vivo T cell surface phenotypes using p-MHC
multimers. For clarity we report four previously defined primary
memory T cell subsets: T effector memory (Tem), T central
memory (Tcm), T double positive effector memory (Tdpem) and T
effector memory RA+ (TemRA). These subsets and their
corresponding phenotypes are shown in Table 2. EBV epitope
GLC9 from the immediate early, lytic protein BMLF1, is included
as a point of reference.
The surface phenotypes of memory T cells specific for SVG9
and SLF9 contained significant numbers of both Tem and Tdpem
cells (Figure 3). For SVG9, Tdpem were most prominent, and few
Tcm cells were found. An unexpected observation was that SVG9
specific T cells displaying a terminally differentiated TemRA
Table 1. Epitopes used to probe WNV specific immunity.
Virus Peptide Sequence Location Protein
WNV SVG9 SVGGVFTSV 430–438 Env
WNV RLD10 RLDDDGNFQL 78–87 NS2b
WNV YTM9 YTMDGEYRL 518–526 NS3
WNV SLT9 SLTSINVQA 15–23 NS4b
WNV SLF9 SLFGQRIEV 68–76 NS4b
WNV ATW9 ATWAENIQV 862–870 NS5
EBV GLC9 GLCTLVAML 280–288 BMLF-1
doi:10.1371/journal.pone.0015343.t001
WNV Specific T Cells
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phenotype were significantly over represented (Figure 3A, bottom
right panel). This is unexpected because TemRA cells are more
common during chronic infections such as human cytomegalovi-
rus [14], while WNV causes an acute, nonpersistent infection,
although this notion was challenged by recently described
evidence [2,3,15]. In summary, T cells specific for SVG9 and
SLF9 are largely Tem and Tdpem and a significant population of
SVG9 specific T cells are of the TemRA phenotype (Figure 3B).
WNV specific memory T cell phenotype differs with age
and disease severity
Because our cohort had no age-related association with disease
severity, we independently examined relationships between WNV-
specific CD8+ T cell phenotypes, disease severity, and age. First we
tested T cell phenotype profiles between subjects who had
neuroinvasive disease and those who did not. For SLF9 specific
cells, the Tdpem subset was overrepresented in subjects who did
not develop neuroinvasive disease (Figure 4A, bottom left panel). A
similar pattern was observed for SVG9, although the mean
percentages were not statistically different. Interestingly, TemRA
cells specific for SVG9 were more common in the neuroinvasive
than in the non-neuroinvasive subjects. This increase in TemRA T
cells in neuroinvasive subjects was specific to SVG9 as no
difference was observed in the percentage of cells specific for
subdominant epitope SLF9 (Figure 4A, bottom right panel).
Finally, the Tem and Tcm median percentages were the same in
both groups for SVG9 and SLF9. Epitope-specific TemRA cells
are associated with WNV neuroinvasive disease while the Tdpem
subset corresponds to a lack of neuroinvasive symptoms
(Figure 4B).
Although age did not correspond to disease severity in our
cohort, we nevertheless investigated CD8+ T cell phenotypes
among defined age groups. When T cell phenotypes were
stratified by age, both the SVG9 and SLF9 specific Tdpem
subtype (CD45RA+ CD27+ CCR72 CD572) differed with age
(Figure 5). The Tdpem phenotype was significantly overrepre-
sented in subjects less than 40 years of age as compared to the
older age groups (Figure 5A). It is worth noting that, as with the
frequency data, there was no significant (p.0.05) gender
differences in phenotype (data not shown). Together these data
demonstrate that the surface phenotype of WNV memory cells
vary with disease severity, age, and epitope specificity
(Figure 5B).
CD8+ T responses are primarily monofunctional with a
high cytolytic potential in neuroinvasive disease
Having identified phenotypes unique to donors with neuroin-
vasive symptoms, we next investigated the functional capacity
SVG9 and SLF9 specific T cells in these patients. The stimulation
of PBMC with SVG9 and SLF9 generated responding T cells that
were primarily monofunctional (51.1% for SVG9 and 71.0% for
SLF9) (Figure 6). Simultaneous expression of all five functions was
evident in the minority of donors for both the SVG9 and the SLF9
epitopes (3/10 in either cohort, data not shown). T cells were
primarily monofunctional and there was no difference in the
polyfunctional capacity of T cells in donors with either
neuroinvasive or nonneuroinvasive symptoms.
The neuroinvasive cohort did demonstrate a significant
increase in the cytolytic associated marker CD107a (Figure 6
top panel). Again, WNV epitope specificity revealed itself as
SVG9 but not SLF9 specific T cells exhibited an augmented
expression of CD107a (Figure 7). This CD107a association with
disease progression is consistent with the TemRA surface
phenotyping data; SVG9 specific TemRA were overrepresented
in neuroinvasive donors and produced CD107a upon antigenic
stimulation.
Figure 1. WNV p-MHC multimer positive T cells are recognized at high frequency in seropositive subjects. Log10 frequency of p-MHC
multimer positive events per 106 CD3+/CD8+ cells from WNV seropositive and WNV seronegative subjects are shown for (A) dominant epitopes and
(B) non dominant WNV epitopes. All comparisons were made using a one-way ANOVA with a Tukey post-hoc test. In all cases, lines represent mean
values.
doi:10.1371/journal.pone.0015343.g001
WNV Specific T Cells
PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e15343
Discussion
Understanding the phenotype and functional status of T cells
during a successful immune response, as well as during disease
progression, is needed for the design of anti-viral immune
interventions. The characterization of T cells following vaccina-
tion (YFV, vacccinia) or during chronic viral infection (HIV, EBV)
indicates that particular T cell phenotypes and functional status
mediate infection, yet T cell responsiveness varies from vaccine-to-
vaccine and from virus-to-virus [14]. The blueprint continues to
emerge in regards to the T cell response(s) that a successful vaccine
or immune therapy must elicit. As T cell responses play an
important role in the resolution of WNV infections, in this study
we characterized WNV-specific memory CD8+ T cells in patients
that resolve their infection, in patients with neuroinvasive disease,
and stratified by age. Our data show that disease severity, age, and
Figure 2. Frequency of SVG9 but not SLF9 specific cells
increase with age. Log10 frequency of p-MHC multimer positive cells
specific for SVG9 (A) and (B) SLF9 WNV epitopes vs age. The linear
regression model is shown with the 95% confidence bands. Log10
frequency of SVG9 (C) and SLF9 (D) p-MHC multimer positive cells were
divided into three age groups: subjects #40, 41–59, and $60 at time of
infection. For (C) data did not fit a normal distribution so a Kruskal-
Wallis ANOVA was used with Dunn’s method of comparative analysis
and medians are shown.
doi:10.1371/journal.pone.0015343.g002
Table 2. Memory T cells subsets and their surface phenotype.
CD45RA CD27 CCR7 CD57
Tcm 2 + + 2
Tem 2 + 2 2
Tdpem + + 2 2
TemRA + 2 2 +
doi:10.1371/journal.pone.0015343.t002
Figure 3. The phenotype of WNV SGV9 and SLF9 specific cells
differs from that of EBV specific cells. (A) Prevalent memory
phenotypes of antigen experienced T cells are shown, based on
expression of CD27, CD45RA, CCR7, CD57 as defined in Table 2. For data
that did not fit a normal distribution a Kruskal-Wallis ANOVA was used
with Dunn’s method of comparative analysis and medians are shown. In
all other cases a one way ANOVA with a Tukey post-hoc test was used
and means are shown. (B) The size of each cell represents the median
percentage of the prevalent memory phenotypes for each of the
epitopes examined in (A).
doi:10.1371/journal.pone.0015343.g003
WNV Specific T Cells
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epitope specificity are associated with changes in memory T cell
phenotype and frequency.
Our most immediate objective was to examine T cell frequencies:
Immune senescence is receiving considerable attention as a risk
factor during acute WNV infections in that increasing age
corresponds to greater disease severity [12]. During influenza virus
infections [16,17] the frequency of virus-specific T cells decreases
with age, and we posited that this would occur with WNV as well.
Such was not the case, and the frequency of T cells specific for the
immunodominant SVG9 epitope actually increased with age. These
data demonstrate that CD8+ T cell immunity to WNV can increase
as one grows older and that a dearth of WNV specific CTL
mediated immunity does not correspond to disease progression.
Although T cell frequencies for the dominant WNV/A*0201
epitope increased with age, a previous study [11] found that the
number of IFN-c secreting T cells specific for SVG9 & SLF9 did
not increase as patients aged. The data presented here resolve this
discrepancy between total T cell numbers and IFN-c secretion.
First, the ICS data presented here reiterate that the frequency of
IFN-c producing SVG9 memory T cells does not increase with
age (Figure S3A and B). However, when the activation markers
CD107a, TNFa, IL2, and MIP1b are factored into the analysis,
the number of SVG9 responsive T cells significantly increases with
age (Figure S3C and D). These data demonstrate that the number
of T cells responding to the immunodominant SVG9 epitope
increase with age and that these T cells are functionally diverse.
Disease outcome was found to be independent of T cell
frequency, and the next logical step was to characterize the
phenotype of responding T cells. Four T cell categories were tested
(Tdpem, TemRA, Tcm, Tem), and the largest proportion of
WNV specific T cells exhibited a Tdpem phenotype. This memory
CD8+ T cell subset was recently identified as the predominant
subset following vaccination with YFV17D [7], suggesting that
Tdpem correspond with protection from flaviviral infection. In
addition to the Tdpem phenotype, Tem cells were observed for
both SVG9 and SLF9, and for the SVG9 epitope a substantial
number of TemRA cells were identified following infection. The
Tdpem memory T cell surface phenotype is consistent with that of
YFV17D vaccination and may represent a paradigm of protection
for flaviviral infections.
Figure 4. Distinct Phenotype of SGV9 and SLF9 specific cells correlate with neuroinvasive symptoms. (A) Memory phenotypes of
antigen experienced T cells from donors with or without neuroinvasive symptoms are shown, based on expression of CD27, CD45RA, CCR7, CD57 as
defined in Table 2. For data of a normal distribution, lines represent mean values and p values are from a student t-test analysis. For data of a non-
normal distribution, lines represent median values and p values are from a Mann-Whitney test. (B) The size of each cell represents the median
percentage of the prevalent memory phenotypes for each of the two clinical conditions.
doi:10.1371/journal.pone.0015343.g004
WNV Specific T Cells
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Neuroinvasive diseases including encephalitis, meningitis and
meningoencephalitis, represent the most severe conditions follow-
ing WNV infection, and the relationship of T cell phenotypes and
neuroinvasive outcomes was examined. Most interesting was the
observation that significantly more CD45RA was expressed on by
the SVG9-specific CD8+ T memory cells of donors with
neurological involvement. These T cells expressed CD57, the an
indicator of low proliferation potential, and lacked expression of
CD27, confirming their terminally differentiated TemRA pheno-
type [18]. This increase in the frequency of T effector memory
CD45RA+ cells following neuroinvasive infections is the first
indication that changes in T cell immunity are directly associated
with WNV disease severity.
TemRA cells are most commonly observed during chronic
infections where antigen persists after a primary infection with
pathogens such as HIV and herpesviruses [14]. Unlike these
viruses, WNV infection is classified as an acute infection where
sterile immunity is achieved. However, this perception may be
evolving as WNV has been shown to persist in individuals with
neurologic symptoms and given the observation that symptomatic
WNV infections result in long term chronic symptoms. In
addition, WNV RNA has been isolated from the urine of
convalescent patients years after the primary infection [3].
TemRA cells may therefore indicate that WNV antigen remains
following infection. Alternatively, an elevation in CD57 expressing
TemRA cells in those with neuroinvasive disease may be a vestige
of a strong proliferative response during the primary acute
infection. Longitudinal studies that assess changes in virus-specific
immunity and that test for residual virus will help to elucidate the
cause and effect relationship of neuroinvation and TemRA cells.
Tdpem cells that follow YFV vaccination have a polyfunctional
phenotype in that each cell produces .4 different immune
mediators in addition to degranulation [7,8]. Polyfunctional T
cells have also been shown to be advantageous for the control of
HIV, and we next characterized the functional status of WNV-
specific T cells. We found that the majority of infected donors have
Figure 5. Distinct Phenotype of SGV9 and SLF9 specific cells correlate with donor age. (A) Memory phenotypes of antigen experienced T
cells from donors separated by age group are shown, based on expression of CD27, CD45RA, CCR7, CD57 as defined in Table 2. For data of a normal
distribution, lines represent mean values and p values are from a student t-test analysis. For data of a non-normal distribution, lines represent median
values and p values are from a Mann-Whitney test. (B) The size of each cell represents the median percentage of the prevalent memory phenotypes
for each age group.
doi:10.1371/journal.pone.0015343.g005
WNV Specific T Cells
PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e15343
WNV specific T cells that are monofunctional. In comparison to T
cell functionality following vaccination with the YFV vaccine,
differences in polyfunctional responses could be due to a difference
in natural infection with wild-type WNV as compared to
vaccination with live attenuated 17D YFV. Alternatively,
differences in the class I HLA/flaviviral peptide complexes tested
for WNV and YFV T cell recognition might contribute to
differences in the measurement of polyfunctional T cells – each of
the six WNV peptides tested here behaved differently.
In summary, we used six high-confidence WNV peptide
epitopes to dissect memory T cells that remain following viral
infection. T cells specific for two immunodominant WNV epitopes
were detectable well after the infection was resolved and the
frequency of these WNV specific T cells remained unchanged and,
in some cases, increased with age; age and disease severity do not
coincide with a dearth of immune reactivity. Surface phenotyping
demonstrates that the majority of memory T cells have a Tdpem
phenotype consistent with YFV17D vaccination, although T cells
that respond to a natural WNV infection are predominatly
monofuntional. In regards to neuroinvasive pathologies, T cells
with a terminally differentiated phenotype represent a post-
infection marker for neuroinvasive pathologies, implicating
persistence of WNV antigens. Finally, age and neuroinvasive
changes associated with WNV infection were specific to the
dominant SVG9/A*0201 epitope complex and did not extend to
the 5 other WNV epitopes presented by HLA-A*0201. Future
studies of the acute immune responses that give rise to these
memory T cell subsets are needed, and these studies may require
both dominant and subdominant epitopes in order to identify
immune response that coincide with disease progression.
Materials and Methods
Ethics Statement
Peripheral blood was collected from consenting subjects
diagnosed with WNV in heparinized tubes in accordance with a
protocol approved by the University of Pittsburgh IRB and the
Research Ethics Board at McMaster University. For all donors,
written, informed consent was obtained before enrolment into the
study in accordance with a protocol approved by the University of
Pittsburgh IRB and the Research Board at McMaster University.
Patients and peripheral blood mononuclear cells (PBMC)
preparation
Subjects were enrolled in the study following presentation of
symptoms of WNV infection at local primary care clinics and
Figure 6. Responses of CD8+ cells stimulated with the SGV9 or SLF9 WNV peptide epitopes are predominantly monofunctional.
PBMC from subjects with or without neuroinvasive disease were stimulated with the immunodominant SVG9 or subdominant SLF9 WNV peptide
epitopes and functional responses were evaluated by multi-color flow cytometry. Percentages of CD8+ T cells expressing the markers shown were
input in the SPICE software for display. Pies represent the distribution of responses by function for each group according to the color scheme below.
Bars represent the level of response for each individual of the 32 different marker combinations. Asterisks indicate significant differences (p,0.05) by
Wilcoxon signed -rank test.
doi:10.1371/journal.pone.0015343.g006
WNV Specific T Cells
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detection of serum IgM by public health laboratories. HLA
genotypes were determined using DNA sequence analysis at Pure
Transplant Solutions (Oklahoma City, OK). Forty subjects
expressing HLA A*0201 allele were selected for phenotype
screening of WNV specific memory CD8+ T cells, using previously
defined HLA A*0201 class I WNV specific multimers (Table 1).
Memory responses were measured from peripheral blood samples
collected 6–7 months post symptom onset. Subject data are
summarized in Table 3. Of the forty patients, 10 were diagnosed
with encephalitis according to CDC guidelines. A control group of
9 WNV seronegative, HLA A*0201 subjects and 2 WNV
seronegative HLA A*0201 negative subjects from Pittsburgh
Central Blood Bank were also included in the study. PBMCs were
isolated from the blood samples by centrifugation on Ficoll
(Amersham Pharmacia) and cryopreserved in RPMI 1640
medium (Invitrogen) containing 12.5% human serum albumin
(Sigma) and 10% DMSO (Invitrogen).
p-MHC multimer staining and detection
To determine the frequency of peptide-specific T cells in
PBMC, cells were thawed on the same day of the assays, let
recover for 2 hours at 37uC, then treated with 100 mg/ml of
DNase I (Sigma-Aldrich), and washed twice in monoclonal wash
buffer (HBSS with 0.01% NaN3, 1% FBS). After recovery,
PBMC were incubated for 10 minutes at room temperature with
individual WNV specific p-MHC multimers (ProImmune).
Afterwards, cells were washed and then stained for 20 min at
4uC with monoclonal antibodies directed against cell surface
antigens: CD3-APC-H7 and CD8 PerCP-Cy5.5 for T cell
lineage; CD57-FITC, CD45RA- PE-Cy7 (all from BD Biosci-
ences), CCR7-PE (R and D Systems) and CD27 PE-Cy5
(Beckman-Coulter) for T cell memory phenotyping; CD4,
CD14, CD16 and CD19 were used to exclude cells binding
nonspecifically to the p-MHC multimers (dump channel) and
were labeled either with PE-TexasRed (Beckman-Coulter) or
with V-450 (BD Biosciences); APC fluorotag (ProImmune) for p-
MHC multimer identification. Cells were then washed and
resuspended in stabilizing fixative (BD Biosciences) and analyzed
on a FACS LSRII (BD Biosciences) within 24 hours. Color
compensation was set up with every assay using mouse Ig binding
beads (BD Biosciences). PBMC from HLA A*0201 WNV
seronegative subjects were treated as described above and used
as negative controls. HLA A*0201 restricted BMLF-1 EBV
multimer (GLCTLVAML) was used as positive control. At least
100,000 events were collected from each subject. Data were
analyzed with DIVA software (BD).
Figure 7. Cytolytic responses of CD8+ cells stimulated with the
SGV9 immunodominant WNV peptide are augmented in
subject with neuroinvasive involvement. PBMC from donors with
or without neuroinvasive disease were stimulated with the immuno-
dominant SVG9 or subdominant SLF9 peptide WNV epitopes and
functional responses were evaluated as described. Percentages of CD8+
T cells expressing the cytotoxicity surrogate marker CD107a were added
for each of the 32 combinations shown in Figure 5 using SPICE
software. Pies represent the distribution of CD107a positive (red) and
negative (green) for the two epitopes. Bars represent the interquartile
range (25% –75%) of the CD107a response for the two cohorts.
Wilcoxon signed-rank test was performed for the two antigens.
doi:10.1371/journal.pone.0015343.g007
Table 3. WNV infected donors.
Subject ID Sex Age
Days post-
diagnosis Clinical condition
77406 M 80 211 Neuroinvasive
05201 M 39 239 Non-Neuroinvasive
77411 F 48 125 Non-Neuroinvasive
55414 M 57 222 Non-Neuroinvasive
55407 M 63 210 Non-Neuroinvasive
77425 M 66 248 Neuroinvasive
77420 M 67 257 Non-Neuroinvasive
77403 F 61 256 Non-Neuroinvasive
77416 M 61 236 Non-Neuroinvasive
77413 M 37 230 Neuroinvasive
77407 F 23 216 Non-Neuroinvasive
55410 M 51 212 Non-Neuroinvasive
77409 F 81 249 Non-Neuroinvasive
77405 M 64 226 Neuroinvasive
55413 M 51 218 Neuroinvasive
55421 M 42 201 Non-Neuroinvasive
55415 F 43 240 Non-Neuroinvasive
77319 F 41 204 Non-Neuroinvasive
77330 F 45 190 Non-Neuroinvasive
77322 F 55 221 Non-Neuroinvasive
55303 F 53 222 Non-Neuroinvasive
77316 M 45 256 Non-Neuroinvasive
77303 F 57 236 Neuroinvasive
77327 M 47 271 Non-Neuroinvasive
77324 M 39 229 Non-Neuroinvasive
77311 M 64 231 Neuroinvasive
55319 M 47 216 Non-Neuroinvasive
77312 F 45 235 Neuroinvasive
77332 F 60 .200 Neuroinvasive
77307 F 55 184 Neuroinvasive
IDSA19 F 64 552 Non-Neuroinvasive
IDSA28 M 20 .200 Non-Neuroinvasive
IDSA12 M 61 86 Non-Neuroinvasive
IDSA30 M 57 556 Non-Neuroinvasive
IDSA31 F 37 237 Non-Neuroinvasive
IDB203 M 49 280 Non-Neuroinvasive
IDS104 M 41 362 Non-Neuroinvasive
IDS123 F 34 .200 Non-Neuroinvasive
IDS41 F 62 327 Non-Neuroinvasive
IDB157 M 64 261 Non-Neuroinvasive
doi:10.1371/journal.pone.0015343.t003
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Gating strategy and validation of WNV specific p-MHC
multimers
To identify and enumerate epitope-specific CD8+ cytotoxic T
cells, we used peptide HLA *0201 multimeric complexes specific for
six individual HLA A*0201-restricted WNV epitopes previously
discovered by mass spectroscopy and validated by functional testing
(Table 1) in a WNV infected cohort (Table 3) [10]. In Figure S1, the
polychromatic (8 color) multiparameter gating strategy used to
identify WNV specific CD8+ T cells is described. CD4/CD14/
CD16/CD19 positive cells were excluded (dump channel) to select
T cells of CD8 lineage (CD3+/CD8+). Within this population the
phenotypic distribution of memory markers expressed by WNV p-
MHC specific T cells (i.e. CD45RA, CD27, CCR7 and CD57) was
determined. Gate positions for CD45RA, CD27, CCR7 and CD57
were set for each donor based on the phenotype distribution of
pMHC multimer negative CD8+ CD3+ cells. CD8+ T cells specific
for the different A*0201/WNV peptides were thus enumerated and
characterized in PBMC of WNV seropositive donors. To account
for background in subsequent analyses, the frequency of CD8+ cells
reacting with only the APC fluorotag was subtracted from the
epitope specific frequencies for each donor. Thus, donor whose p-
MHC cell frequency was below the APC fluorotag background
frequency (negative group) were separated from those who were
above (positive group). This resulted in 34/40 (85%), 34/40 (85%)
and 33/40 (82.5%) of subjects positive for SVG9, SLF9 and EBV,
respectively, in the positive group. The positive group was used for
subsequent phenotypic analysis. To further ensure phenotypic
analysis was not affected by background we grouped the samples by
donors having frequencies below 3X FMO and by donors above 3X
FMO. We then compared the phenotype distributions between
these two groups. We found no significant difference p.0.05 in the
median percentages with any phenotype (data not shown).
Evaluation of CD8+ T cell polyfunctionality
Cryopreserved PBMC from a total of 20 WNV infected donors
(10 non-neuroinvasive and 10 neuroinvasive) were thawed for
intracellular cytokine staining (ICS) and analyzed by flow
cytometry in order to measure the expression of the following
immune mediators: IFNc, TNFa, IL-2, MIP-1b, and CD107a.
Cells were rested in media overnight at 37uC and then washed.
Aliquots of 106cells were then co-cultured with the immunodomi-
nant WNV Env peptide (SVG9, 10 mg/ml), anti-CD107a mAb
FITC (BD Bioscience), GolgiStop and GolgiPlug (BD Bioscience)
in a 96-well plate. The negative control was medium only and the
positive control was cells stimulated with Staphylococcus enterotoxin
B (SEB) (5 mg/ml, Sigma). Plates were incubated at 37uC for 6 h
and then stained for viability with the amine-binding dye Aqua
(Invitrogen) and then washed. Cells were then simultaneously
stained with anti-CD3 mAb PE-Cy7 (BD Bioscience), anti-CD8
mAb PerCP-Cy5.5 (BD Bioscience), anti-CD4 mAb, anti-CD14
and anti-CD19 (all V450 conjugated; ‘‘dump channel’’; BD
Pharmingen), incubated in the dark for 30 minutes at room
temperature (RT), and then washed. The plates were washed with
cold buffer, treated with BD FACS Permeabilizing Solution 2
(200 ml/well), incubated for 10 minutes at RT, and then washed
with 200 ml/well of the cold buffer. The following mAb were then
added: anti-TNFa PE-Cy7 (BD Bioscience), anti-MIP-1b PE (BD
Pharmingen), anti-IL2 APC (5 mL, Biolegend), and anti-IFNc
AF700 (BD Bioscience). The plates were incubated in the dark for
30 min, washed with 150 ml/well of cold buffer, and fixed with 1%
paraformaldehyde in PBS. Cells were analyzed using a LSR-II 12-
color flow cytometer (BD Biosciences). Polyfunctional responses to
peptide or mitogenic stimuli were subtracted from cultures
incubated with medium alone and assessed using the SPICE
program (Version 4.3, Mario Roederer, Vaccine Research Center,
NIAID, NIH). The complete gating strategy for these samples is
detailed in Figure S2.
Statistical analysis
The frequency of antigen specific, p-MHC reactive T cells does
not follow a normal istribution [19] and for this reason all
subsequent statistical analysis on memory cells was performed on a
normalized distribution of log transformed data. Multimer positive
cells were divided by total CD3+CD8+ cells. This number was
then represented as events per million (multiplied by 10e6) rather
than a percent (multiplied by 100). The frequency was then log
transformed and reported as log 10 p-MHC positive cells per
million CD8+ CD3+ cells. Donors with no response in any assay
were removed from analysis. In all cases of regression analysis, a
linear regression model was used. R squared values were
considered significant when p,0.01. All data were tested for a
normal distribution using the Kolmogorov-Smirnov test p.0.05.
Data considered to be normally distributed were analyzed using
either an unpaired t-test or a one way ANOVA with a tukey post-
hoc test and these data were summarized as means. When data
were not normally distributed, a Mann-Whitney or a Kruskal-
Wallis ANOVA with Dunn’s method was used and these data
were summarized as medians. For polyfunctional responses, a
Wilcoxon signed-rank test used. All data was analyzed using
GraphPad Prism software v4.01.
Supporting Information
Figure S1 Gating strategy for the identification and
characterization of WNV p-MHC multimer positive CD8
T cells. Polychromatic (8 color) staining of HLA-A*0201
restricted p-MHC multimer WNV specific CD8 + T cells from
representative subject IDSA30. The gating strategy firstly identifies
‘‘singlets’’ by plotting forward scatter area versus forward scatter
height. The singlet gate is further depleted of events identified by
CD4/CD14/CD16/CD19 (dump channel) to reduce non-specific
background staining. Gated CD3+ events are then plotted against
forward scatter to identify T cells. Following this, T cells of CD8
lineage are plotted against APC labeled multimers and finally
multimer positive events are characterized for the phenotypic
distribution of memory markers (CD45RA/CD57/CCR7/CD27)
within the multimer positive population.
(TIF)
Figure S2 Gating strategy for the identification and
characterization of poly-functional CD8 T cells respond-
ing to WNV immunodominant peptides. After gating in the
singlet events by forward scatter (height versus width) dead cells
were excluded with the use of amino binding stain Aqua, cells
known to bind non specifically to p-MHC multimers were further
excluded via a ‘‘dump’’ channel consisting of antibodies to CD4,
CD14, CD16 and CD19. The resulting cells were further gated for
expression of CD3 and CD8 and then CD8 cells plotted against
each single function.
(TIF)
Figure S3 Correlations with age and cytokine produc-
tion. Cells were stimulated with either SVG9 (A and C) or SLF9
(B and D) and assayed for cytokine production using intracellular
cytokine staining (ICS). Log10 frequency of IFN-c producing cells
(A and B) or cells making any functional marker by ICS (C and D)
versus age.
(TIF)
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